Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Meningeal Neoplasms × eribulin × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 5 Breast Neoplasms 4 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1

Interventions

Trastuzumab 2 Radiotherapy 2 Capecitabine 2 tucatinib 1 sapanisertib 1 pertuzumab 1 patritumab deruxtecan 1 paclitaxel-Angiopep-2 conjugate 1 omburtamab I-131 1 fludarabine 1 eribulin 1 avelumab 1 WP 744 1 Temozolomide 1 Rituximab 1 Methotrexate 1 Cyclophosphamide 1 Amplified Fragment Length Polymorphism Analysis 1 AZD1390 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03613181 2023-04-24

ANGLeD

Angiochem Inc

Phase 3 Unknown

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡